AHA comments regarding H.R. 5378, Lower Costs, More Transparency Act, provisions.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
The Agencies now offer draft merger guidelines that provide virtually no meaningful guidance to hospitals and health systems. The Draft Guidelines ignore serious flaws in contemporary enforcement practice and overlook recent judicial opinions that contradict their more aggressive proposed changes. The Agencies propose a structural presumption that is arbitrarily low and potentially fatal to beneficial transactions.
AHA comments on certain financial products patients may use to pay for medical care (medical payment products).
AHA comments on the Centers for Medicare & Medicaid Services’ (CMS) physician fee schedule (PFS) proposed rule for calendar year (CY)
2024.
AHA comments on the CMS' hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year (CY) 2024.
American Hospital Association opposes the Federal Trade Commission’s proposed amendments to the Hart-Scott-Rodino (HSR) form and instructions.
AHA's comment on the calendar year (CY) 2024 HH prospective payment system (PPS) proposed rule.
AHA comments on the CMS' proposed changes on how certain forms of noncomprehensive coverage, including short-term, limited-duration plans, can be marketed and sold.
AHA voices support of the GOLD Card Act of 2023 (H.R. 4968).
AHA's comments on Energy and Commerce Committee Chair Rodgers’ drug shortages discussion draft.